Dermatology and Inflammatory Skin Disease
Institut Pasteur is involved in clinical research on hidradenitis suppurativa, with a focus on Hurley stage 2 active disease and its persistent inflammatory skin lesions.
- Hidradenitis suppurativa
- Hurley stage 2 disease
- Active inflammatory skin lesions
The sponsor’s trial activity is centered on treatment options for patients with chronic, recurrent skin inflammation requiring targeted therapeutic management.
Antibacterial Therapy
Its research portfolio includes interest in antibiotic-based treatment strategies for skin-related infection and inflammation, particularly combinations used in complex bacterial-driven dermatoses.
- Adapted antibiotherapy
- Combination antibiotic regimens
- Skin and soft tissue infection control
This area reflects a therapeutic emphasis on antimicrobial approaches for conditions where infection and inflammation overlap.
Chronic Inflammatory Disease Management
The funded research addresses long-term disease control in a chronic relapsing disorder, with attention to symptom reduction and clinical improvement in persistent suppurative disease.
- Chronic relapsing inflammation
- Suppurative skin disease
- Therapeutic response assessment
Clinical interest extends to treatment choices relevant to ongoing management of difficult-to-control dermatologic inflammation.
